Fulcrum Therapeutics Inc. (FULC)
Fulcrum Therapeutics Statistics
Share Statistics
Fulcrum Therapeutics has 53.98M shares outstanding. The number of shares has increased by -13.15% in one year.
| 53.98M |
| -13.15% |
| 0.08% |
| 82.88% |
| n/a |
| 11,937 |
| 2.12% |
Short Selling Information
The latest short interest is 4.93M, so 9.13% of the outstanding shares have been sold short.
| 4.93M |
| 9.13% |
| 11.83% |
| 4.51 |
Valuation Ratios
The PE ratio is -29.96 and the forward PE ratio is null. Fulcrum Therapeutics's PEG ratio is 0.34.
| -29.96 |
| n/a |
| 3.64 |
| 4.8 |
| 1.2 |
| -116.72 |
| 0.34 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Fulcrum Therapeutics.
| n/a |
| n/a |
| n/a |
| n/a |
Financial Position
The company has a current ratio of 22.63, with a Debt / Equity ratio of 0.04.
| 22.63 |
| 22.63 |
| 0.04 |
| -0.47 |
| -3.46 |
| 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| n/a |
| n/a |
| n/a |
| $1,777,777.78 |
| $-216,111.11 |
| 45 |
| 0.31 |
| n/a |
Taxes
| n/a |
| 0% |
Stock Price Statistics
The stock price has increased by -15.05% in the last 52 weeks. The beta is 2.42, so Fulcrum Therapeutics's price volatility has been higher than the market average.
| 2.42 |
| -15.05% |
| 4.65 |
| 4.36 |
| 70.26 |
| 561,995 |
Income Statement
In the last 12 months, Fulcrum Therapeutics had revenue of 80M and earned -9.72M in profits. Earnings per share was -0.17.
| 80M |
| 78.41M |
| -21.9M |
| -9.72M |
| -18.24M |
| -19.83M |
| -0.17 |
Balance Sheet
The company has 58.21M in cash and 8.63M in debt, giving a net cash position of 49.58M.
| 58.21M |
| 8.63M |
| 49.58M |
| -519.4M |
| 242.65M |
| 224.46M |
Cash Flow
In the last 12 months, operating cash flow was -2.22M and capital expenditures -278K, giving a free cash flow of -2.5M.
| -2.22M |
| -278K |
| -2.5M |
| -0.04 |
Margins
Gross margin is 98.01%, with operating and profit margins of -27.37% and -12.16%.
| 98.01% |
| -27.37% |
| -12.16% |
| -12.16% |
| -22.8% |
| -27.37% |
| -3.12% |
Dividends & Yields
FULC does not appear to pay any dividends at this time.
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
Analyst Forecast
The average price target for FULC is $4, which is -43.7% lower than the current price. The consensus rating is "Hold".
| $4 |
| -43.7% |
| Hold |
| 7 |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| n/a |
| n/a |
| n/a |
| n/a |
Scores
| 14.02 |
| 5 |